Maximizing Your Success with ProSci’s Custom Monoclonal Antibody Services – The monoclonal antibody market is expected to reach $524.68 billion by 2030. This highlights the growing demand for monoclonal antibodies in biomedical research, diagnostics, and therapeutic development. Monoclonal antibodies (mAbs)...
Share this post:
In this blog, ProSci will take you through the advantages of single domain antibodies—also known as Nanobodies™, VHH antibodies, and camelid antibodies—and the process ProSci uses to develop high-performing antibodies. Single Domain Antibodies (sdAbs) from the camelid family are exciting...
Share this post:
